683 Capital Management’s ProMIS Neurosciences PMN Stock Holding History
Bought
Maintained
Sold
Other funds holding PMN
YF
683 Capital Management's PMN Position: Q3 2026 in Review
683 Capital Management increased its ProMIS Neurosciences (PMN) stake by 163% in Q3 2026, buying an estimated $2.11M and bringing the position to 250,000 shares worth $2.71M. The position accounts for 0.11% of the portfolio, ranked #93.
683 Capital Management first reported a position in PMN in Q1 2026 and has held it in 3 quarters since. 30 funds tracked by Wall St. Rank hold PMN as of Q3 2026.
- 683 Capital Management held 250,000 shares of ProMIS Neurosciences worth $2.71M as of Q3 2026.
- 683 Capital Management bought 155,000 ProMIS Neurosciences shares in Q3 2026, an estimated $2.11M.
- ProMIS Neurosciences made up 0.11% of 683 Capital Management's portfolio in Q3 2026, its #93 holding.
- 683 Capital Management first reported a position in ProMIS Neurosciences in Q1 2026 and has held it in 3 quarters since.
- 30 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q3 2026.
Based on 683 Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.